Insider · CIK 0001780354
Grace Colon
Files at VYGR (Voyager Therapeutics, Inc.). First filing -, latest -.
In brief
Grace Colon files SEC Form 4 as director at VYGR (Voyager Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Grace Colon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | - | Jun 11, 2026 |
| Jun 3, 2025 | VYGR Voyager Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jun 4, 2025 |
Questions about Grace Colon
Answered from the filings on this page, as of the latest one.
Is Grace Colon buying or selling?
Grace Colon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Grace Colon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Grace Colon has 0.
Where does Grace Colon file Form 4?
Grace Colon has filed Form 4 at VYGR (Voyager Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.